This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Celgene Corporation. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Eun Mi Hur: Innovator in Psoriasis Treatment
Introduction
Eun Mi Hur is a prominent inventor based in Westfield, NJ (US). She has made significant contributions to the field of immunology, particularly in the treatment of autoimmune diseases. Her innovative work focuses on utilizing PD-1 binding antibodies to manage and treat conditions such as psoriasis.
Latest Patents
Eun Mi Hur holds 1 patent for her groundbreaking invention titled "Methods of treating psoriasis using PD-1 binding antibodies." This patent outlines methods for managing, treating, or preventing immune disorders by using proteins that specifically bind to Programmed Death-1 (PD-1). These proteins modulate the expression and activity of PD-1, offering new avenues for treatment.
Career Highlights
Eun Mi Hur is currently employed at Celgene Corporation, where she continues to advance her research and development efforts. Her work at Celgene has positioned her as a key player in the pharmaceutical industry, particularly in the realm of autoimmune disease therapies.
Collaborations
Eun Mi has collaborated with notable colleagues, including Henry Chan and Peter Henry Schafer. These partnerships have further enriched her research and contributed to the development of innovative treatment methods.
Conclusion
Eun Mi Hur's contributions to the field of immunology, particularly in the treatment of psoriasis, highlight her role as a leading inventor. Her work continues to inspire advancements in medical science and offers hope for those affected by autoimmune diseases.